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Abstract
Background: Few data concern the pathophysiology of primary spontaneous pneumothorax (PSP), which is associated with
alveolar hypoxia/reoxygenation. This study tested the hypothesis that PSP is associated with oxidative stress in lung
macrophages. We analysed expression of the oxidative stress marker 4-HNE; the antioxidant and anti-inflammatory proteins
heme oxygenase-1 (HO-1), biliverdin reductase (BVR) and heavy chain of ferritin (H-ferritin); and the transcription factors
controlling their expression Nrf2 and HIF-1a, in lung samples from smoker and nonsmoker patients with PSP (PSP-S and
PSP-NS), cigarette smoke being a risk factor of recurrence of the disease.
Methodology/Principal Findings: mRNA was assessed by RT-PCR and proteins by western blot, immunohistochemistry and
confocal laser analysis. 4-HNE, HO-1, BVR and H-ferritin were increased in macrophages from PSP-S as compared to PSP-NS
and controls (C). HO-1 increase was associated with increased expression of HIF-1a mRNA and protein in alveolar
macrophages in PSP-S patients, whereas Nrf2 was not modified. To understand the regulation of HO-1, BVR and H-ferritin,
THP-1 macrophages were exposed to conditions mimicking conditions in C, PSP-S and PSP-NS patients: cigarette smoke
condensate (CS) or air exposure followed or not by hypoxia/reoxygenation. Silencing RNA experiments confirmed that HIF-
1a nuclear translocation was responsible for HO-1, BVR and H-ferritin induction mediated by CS and hypoxia/reoxygenation.
Conclusions/Significance: PSP in smokers is associated with lung macrophage oxidative stress. The response to this
condition involves HIF-1a-mediated induction of HO-1, BVR and H-ferritin.
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Introduction
Primary spontaneous pneumothorax (PSP), representing a medical
emergency, is an important health problem. PSP is defined as air
occurrence in the pleural space with secondary lung collapse
atelectasis. This disease is common in young, otherwise healthy
people and is frequent in clinical practice (1%-7% of all pulmonary
diseases). Recurrence of pneumothorax is a frequent phenomenon
(approximately 30%) and a critical problem in disease management
[1,2]. Cigarette smoking is suggested as a risk factor for PSP [3] and is
an independent risk factor for recurrence [4].
Few data are available concerning the pathophysiology of PSP
and the role of cigarette smoke in this process. De Smedt and
coworkers [5] showed inflammatory changes in the bronchi, lung
parenchyma and pleural cavity accompanied by anatomical and
histological changes in bronchi and lungs. Oxidative stress could
be involved in the predisposing effects of cigarette smoking
because cigarette smoke contains a high oxidative burden [6].
Indeed, oxidative stress has been implicated in the pathogenesis
of many respiratory diseases, especially those induced by
cigarette smoke [7,8]. In these pulmonary diseases, macrophages
play a crucial role in the oxidative stress response [9,10].
However, no information is available on oxidative stress in lung
macrophages of patients with PSP and its relation with smoking
status.
Heme oxygenase (HO) plays a critical role counterbalancing
oxidative stress. HO catalyses heme degradation producing CO,
which has anti-inflammatory properties; biliverdin converted to
bilirubin, a powerful antioxidant, by biliverdin reductase (BVR);
and free iron bound to the heavy chain ferritin (H-ferritin),
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sensitive, isoform of HO (HO-1) is involved in protection against
inflammation and oxidative stress in different pathological
conditions [11]. Therefore, HO-1 could be induced in the lung
of patients with PSP, especially smokers, to provide protection
against inflammation and oxidative stress. However, to the best of
our knowledge, no data is available on oxidative stress markers
and HO-1 expression in the lungs of patients with PSP, whatever
their smoking status. Therefore, we first aimed to investigate the
mRNA and protein expression of HO-1, BVR and H-ferritin,
along with 4-hydroxynonenal (4-HNE) adducts, a marker of
oxidative stress, in lung biopsies of smoker and non-smoker
patients with and without recurrent PSP disease.
During the pneumothorax condition and treatment, atelectasis
and reexpansion are associated with acute alveolar hypoxia and
reoxygenation, respectively [12]. Therefore, our second aim was to
examine the mechanism(s) involved in inducing HO-1, BVR and
H-ferritin expression in PSP by analyzing the expression of and the
roles of transcription factors involved in signaling events after
hypoxia/reoxygenation and/or cigarette smoke exposure in the
aforementioned lung biopsies and in vitro in a human monocyte/
macrophage cell line (THP-1). We focused on hypoxia inducible
factor 1a (HIF-1a) and nuclear factor erythroid 2-related factor 2
(Nrf2) [13,14].
Results
Characteristics of lung samples
Histological analysis of lung biopsies showed inconstant
subpleural areas of fibrosis with adjacent subpleural bullae in
primary spontaneous pneumothorax patients (PSP), and no
alterations in control patients (C). The number of macrophages
was significantly higher for primary spontaneous pneumothorax
smokers (PSP-S) than primary spontaneous pneumothorax
nonsmokers (PSP-NS) and C patients (p=0.029; Figure 1A).
The groups did not differ in polymorphonuclear neutrophils
(p=0.62) or eosinophils number (p=0.97) (Figure 1B and 1C).
Oxidative stress in PSP-S samples
Immunostaining with 4-HNE was used to assess lipid
peroxidation in the lungs [15]. 4-HNE staining was present in
all lung cells but mainly in macrophages. The staining was
significantly higher for PSP-S than PSP-NS and C groups, for
both increased staining intensity per macrophage and increased
number of positive-stained macrophages (Figure 2 and Table 1,
p,0.03).
Increased expression of HO-1 and other components of
the HO system in PSP-S samples
Immunohistochemical staining for HO-1, BVR and H-ferritin
in lung biopsies was significantly higher for PSP-S than PSP-NS
and C patients (p,0.03; Figure 3), with both increased staining
intensity per macrophage and increased number of positive-
stained macrophages (Figure 3 and Table 1, p,0.03).
Immunostaining with a CD68 antibody in sequential slides
showed that most of the HO-1-positive cells in alveolar spaces
were CD68 positive (88.5% [75.6–94.2]). The same result was
observed with BVR (92.6% [82.7–98.2]) and H-ferritin (94.5%
[85.6–98.5]). We further confirmed increased HO-1 expression
at the protein level by western blot analysis of lung homogenates
(Figure 4). Furthermore, induction of mRNA level of HO-1,
BVR and H-ferritin in PSP-S lung biopsies was confirmed
(Figure S1).
Increased expression of HIF-1a but not Nrf2 in
macrophages in PSP-S samples
Because regulation of HO-1 transcription under oxidant
exposure involves the transcription factors HIF-1a and Nrf2 and
because macrophages are the main cells expressing HO-1, we
investigated the nuclear expression of these transcription factors in
macrophages in lung biopsies by confocal laser microscopy. The
groups did not differ in nuclear expression of Nrf2 protein
(p=0.99; Figure S2). By contrast, HIF-1a protein expression in
both the cytosol and nucleus of alveolar macrophages (CD68-
positive cells) was higher in PSP-S tissue than in PSP-NS and C
tissue, with no difference in expression between PSP-NS and C
groups (Figure 5, p=0.003 for the quantification of nuclear
localization between PSP-S vs. the 2 other groups). This increased
HIF-1a protein expression in macrophages was associated with
increased HO-1 protein expression (Figure 6). The mRNA level of
HIF-1a was also higher in PSP-S lung tissue than in PSP-NS or C
tissue, which suggests transcriptional regulation (Figure 7).
In vitro experiments
To further understand the regulation of HO-1, BVR and H-
ferritin expression in alveolar macrophages, the THP-1 macro-
phage cell line was exposed to conditions mimicking the condition
of C and PSP-S and PSP-NS patients: cigarette smoke condensate
(CS) or air exposure followed or not by hypoxia and reoxygena-
tion. The duration of exposure was as close as possible to the
clinical setting: 24 h pre-exposure to CS, then 4 h hypoxia and up
to 18 h reoxygenation (these 2 last time periods are similar to the
time periods between symptoms and thoracostomy and between
thoracostomy and thoracoscopic pleurodesis, respectively). The
following nomenclature was adopted: R2, R4, R6 and R18,
corresponding to 2, 4, 6 and 18 h, respectively, after the beginning
of reoxygenation. We used 1 mg/ml CS because this dose did not
induce HO-1 expression in THP-1 cells in normoxia. This
condition mimicked the lack of induction of HO-1 expression
observed in C-S patients.
Effect of hypoxia/reoxygenation and CS exposure on
HO-1 expression and related HO components
Cells exposed to CS and hypoxia/reoxygenation did not differ
from untreated or normoxic control cells in cell viability (data not
shown). HO-1, BVR, and H-ferritin protein expression was not
increased at the end of the whole experimental period (R18) in
cells exposed to normoxia or hypoxia/reoxygenation without CS
exposure (Figure 8A–C). By contrast, cells exposed to both CS and
hypoxia/reoxygenation showed an increased expression of HO-1,
BVR, and H-ferritin (Figure 8A–C). The level of expression of the
components of the HO system was inversely related to O2
concentration, the main increase being observed in THP-1 cells
exposed to 0.5% O2 (Table 2).
To better understand HO-1, BVR and H-ferritin induction
mechanisms, we analyzed the kinetics of mRNA level changes
during reoxygenation (Figure S3). CS exposure or hypoxia/
reoxygenation without CS exposure did not induce HO-1
expression, whatever the duration of reoxygenation (Figure
S3A). By contrast, moderate hypoxia (5% O2) potentiated CS-
induced increase in HO-1 mRNA level. HO-1 mRNA
expression was increased significantly at 4 h reoxygenation
(R4) and was maintained until 6 h of reoxygenation (R6). This
effect was more pronounced with severe hypoxia (0.5% O2). A
similar time course effect was observed with BVR and H-ferritin
mRNA levels, but the increased mRNA expression persisted
until 18 h (Figure S3B-C).
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Staining for 4-HNE measured at 18 h reoxygenation (R18) was
increased both in the cytosol and membrane of cells exposed to
both CS and hypoxia/reoxygenation, with the main increase on
exposure to 0.5% O2, which paralleled the increased HO-1, BVR
and H-ferritin expression (Figure 8D and Table 2). Intracellular
reactive oxygen species (ROS) production was significantly
increased in cells exposed to both CS and hypoxia/reoxygenation
as compared to CS alone or hypoxia/reoxygenation without CS
exposure, thereby confirming results observed with 4-HNE
Figure 1. Detection of CD68, elastase and major basic protein (MBP) in lung biopsies. Specific immunohistochemical staining and
quantification of CD68 (A), elastase (B), MBP (C) were assessed in lung biopsies from C-NS, C-S, PSP-NS and PSP-S patients (magnification6200). C-NS
and C-S, control patient nonsmokers and smokers, respectively; PSP-NS and PSP-S, primary spontaneous pneumothorax nonsmokers and smokers,
respectively. Box-and-whiskers plot with median, interquartile range and minimum and maximum values. *p=0.029 for CD68, PSP-S vs. PSP-NS, C-NS
and C-S. Images are representative of all samples.
doi:10.1371/journal.pone.0010886.g001
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reoxygenation period (R2) to 18 h reoxygenation (R18).
Effect of hypoxia/reoxygenation and CS exposure on
HIF-1a and Nrf2 expression
To examine a possible cause-effect relationship between the
increase in HIF-1a ´ and HO-1, BVR and H-ferritin levels observed
in PSP-S samples, we first investigated whether the increased
expression of HO-1, BVR, and H-ferritin was associated with
increased nuclear expression of HIF-1a in the different in vitro
experimental conditions. In addition, we analyzed nuclear Nrf2
protein expression.
Because the increase in HO-1, BVR and H-ferritin mRNA
expression was observed at R4, we analyzed HIF-1a nuclear
protein expression at this time point. HIF-1a nuclear protein
expression was significantly increased in cells exposed to CS and
hypoxia/reoxygenation at R4 and returned to the basal level at
R6; Nrf2 nuclear protein expression showed no change (Figures 9–
10). Cells exposed to CS or hypoxia/reoxygenation alone showed
no modification of HIF-1a or Nrf2 expression (Figures 9–10). The
increased HIF-1a protein expression in cells exposed to both CS
and hypoxia/reoxygenation was confirmed at the mRNA level
(Figure S4).
Effects of HIF-1a silencing
To investigate the role of HIF-1a in HO-1, BVR and H-
ferritin induction, we performed RNA silencing experiments. We
first confirmed the efficiency of HIF-1a siRNA transfection by a
decreased HIF-1a level both in cytosolic and nuclear compart-
ments on confocal analysis and decreased HIF-1a mRNA
expression (data not shown). Western blot analysis confirmed
that HIF-1a siRNA transfection completely abrogated the
Figure 2. Oxidative stress in lung biopsies. Specific immunohistochemical staining and quantification of 4-HNE (a marker of oxidative stress) were
assessed in lung biopsies from C-NS, C-S, PSP-NS and PSP-S patients (magnification 6200). Abbreviations are in Figure 1. Box-and-whiskers plot with
median, interquartile range and minimum and maximum values. *p,0.03 PSP-S vs. PSP-NS, C-NS and C-S. Images are representative of all samples.
doi:10.1371/journal.pone.0010886.g002
Table 1. Quantification of HO-1-, BVR-, H-ferritin- and 4-HNE-positive macrophages (CD68 positive cells) in lung biopsies from C-
NS, C-S, PSP-NS and PSP-S patients.
C-NS C-S PSP-NS PSP-S
HO-1 staining 0 15.2 [11.0–18.3] 14.1 [9.1–22.1] 13.2 [9.5–20.7] 2.7 [1.5–6.8] *
+ 78.9 [72.6–82.8] 80.3 [72.5–81.9] 76.3 [73.0–80.7] 16.2 [13.2–20.0] *
++ 6.9 [3.7–9.7] 5.4 [3.7–11.1] 9.4 [6.3–12.0] 79.7 [78.3–82.7] *
BVR staining 0 18.9 [15.5–22.7] 16.0 [13.7–23.2] 24.8 [17.0–33.3] 3.1 [1.8–8.0] *
+ 67.4 [56.4–73.2] 76.1 [67.2–79.2] 63.6 [59.2–72.7] 19.9 [17.2–25.1] *
++ 11.7 [9.7–26.4] 8.1 [6.3–10.0] 9.9 [7.5–13.7] 75.8 [71.6–78.8] *
H-ferritin staining 0 11.9 [9.5–15.6] 15.0 [9.6–25.0] 14.9 [10.5–30.1] 2.5 [0.6–6.7] *
+ 60.3 [57.5–72.9] 60.7 [54.8–64.2] 63.8 [50.6–71.2] 11.2 [3.0–18.9] *
++ 24.9 [17.7–32.8] 27.0 [12.7–28.3] 19.5 [16.8–24.3] 84.6 [77.6–96.4] *
4-HNE staining 0 24.0 [20.1–27.9] 17.0 [13.7–22.7] 20.0 [14.7–21.9] 0.5 [0.2–1.9] *
+ 73.8 [69.5–78.0] 79.4 [72.2–83.7] 77.7 [74.5–81.3] 6.7 [5.7–8.4] *
++ 2.4 [1.5–2.6] 3.8 [1.3–6.0] 3.2 [1.8–4.0] 92.6 [90.7–93.7] *
0 = absent staining; + = moderate staining; ++ = intense staining.
C-NS = control patient non-smokers; C-S = control patient smokers; PSP-NS = primary spontaneous pneumothorax non-smokers; PSP-S = primary spontaneous
pneumothorax smokers.
HO-1 = heme oxygenase-1; BVR = biliverdin reductase; 4-HNE = 4-hydroxynonenal.
Results are presented as median [min-max] percentage, * p,0.03 vs C-NS, C-S, PSP-NS.
doi:10.1371/journal.pone.0010886.t001
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hypoxia/reoxygenation (Figure 11). HIF-1a siRNA transfection
also completely abrogated the increased HO-1, BVR and H-
ferritin mRNA levels, thus confirming the transcriptional
regulation of HO-1, BVR and H-ferritin mRNA by HIF-1a
(Figure 12).
Discussion
This study shows that the expression in lung macrophages of
both the oxidative stress marker 4-HNE and antioxidant and anti-
inflammatory proteins HO-1, BVR and H-ferritin is significantly
higher in patients with PSP exposed to cigarette smoke (PSP-S)
Figure 3. Detection of HO-1, BVR and H-ferritin in lung biopsies. Specific immunohistochemical staining and quantification of HO-1 (A), BVR
(B), and H-ferritin (C) were assessed in lung biopsies from C-NS, C-S, PSP-NS and PSP-S patients (magnification 6200). Abbreviations are in Figure 1.
Box-and-whiskers plot with median, interquartile range and minimum and maximum values. *p,0.03 PSP-S vs. PSP-NS, C-NS and C-S. Images are
representative of all samples.
doi:10.1371/journal.pone.0010886.g003
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control patients. The mRNA and protein expression and protein
nuclear localisation of the transcription factor HIF-1a followed the
same pattern as and colocalized with HO-1, whereas the
expression and nuclear localisation of the transcription factor
Nrf2 was not modified in patients with PSP. In vitro experiments in
a human monocyte/macrophage cell line, THP-1, cultured under
conditions mimicking the condition of lung macrophages during
the pneumothorax condition and treatment in smokers (CS
exposure with short hypoxia then reoxygenation) showed that
HIF-1a was responsible for inducing HO-1, BVR and H-ferritin
expression. Collectively, these results show that spontaneous
pneumothorax in smokers is associated with lung macrophage
oxidative stress and the orchestrated induction of the antioxidant
proteins HO-1, BVR and H-ferritin, probably via an HIF-1a
pathway.
Cigarette smoking is suggested as a risk factor for PSP [3] and is
an independent risk factor for recurrence of the disease [4]. The
present results shed some light in the mechanism(s) underlying this
phenomenon because lung biopsies from PSP-S patients showed
high macrophage infiltration and macrophages showed high lipid
peroxidation (4-HNE staining) as compared with lung biopsies
from PSP-NS patients. Our results agree with data published
previously showing inflammatory changes in lung samples from
patients with PSP [5,16]. However, in previous studies, the effect
of CS exposure was only slightly investigated. Furthermore, no
analysis of oxidative stress was performed.
Oxidative stress can predispose to the development and
recurrence of PSP by amplifying and/or perpetuating inflamma-
tion [1,17], which thus provides new elements to understand the
pathophysiology of this disease. The difference between PSP-S and
PSP-NS patients could be related to time between symptoms and
thoracostomy; some studies have found an association of duration
of air in the pleural space and the inflammatory response in the
pleural fluid [18]. However, this situation did not occur in our
study because the time between symptoms and thoracostomy and
between thoracostomy and surgical pleurodesis was similar for all
patients. Moreover, the number and size of previous pneumotho-
races were similar for PSP-S and PSP-NS patients according to
patient history. A prospective study with a detailed description of
events during pneumothorax condition and treatment would be
more relevant to assess differences in oxidative stress between PSP-
S and PSP-NS patients.
To counteract oxidative stress, the organism possesses several
systems. In PSP-S patients, we found a highly orchestrated
response involving the induction of HO-1, BVR and H-ferritin
expression. Although the induction of HO-1 expression has been
demonstrated in several respiratory pathological conditions such as
emphysema, hyperoxia [19], influenza virus infection [20], ozone-
induced lung injury [21] and asthma [22], its involvement in PSP
has not been shown before. Furthermore, no study has
demonstrated the concomitant induction of BVR and H-ferritin,
along with HO-1, in pulmonary and nonpulmonary pathological
conditions. This coordinated response is important from a
functional point of view. Indeed, recent studies showed that
BVR and H-ferritin play critical roles in mediating the
cytoprotective effects of HO-1 against hypoxia/reoxygenation
injury in cardiomyocytes, hepatocytes and endothelial cells
[23,24]. Of note, no induction of HO-1 expression in control
smokers was unexpected. However, these results agree with
previous results from our laboratory and other groups [9,25,26].
Moreover, no staining for 4-HNE in these patients reflects an
absence of oxidative stress, which thus supports no induced
expression of the redox-sensitive HO-1. PSP patients were
younger than control patients and had less cumulative tobacco
exposure. These differences in dose and duration of cigarette
exposure could influence the qualitative and quantitative induction
of the antioxidant HO-1 system in macrophages, because a dose
effect and biphasic expression were evidenced in vitro [10].
During the pneumothorax condition and treatment, atelectasis
and reexpansion are associated with acute alveolar hypoxia and
reoxygenation, respectively [12]. We found induced expression of
Figure 4. Expression of HO-1 protein in lung tissue. A: representative western blot of HO-1 protein expression of lung homogenates from C-
NS, C-S, PSP-NS and PSP-S patients (n=3 each) with the respective b-actin controls. Abbreviations are in Figure 1. B: quantification of HO-1 protein.
Results are expressed as ratio of expression to that of b-actin (n=5, * p,0.012 PSP-S vs. PSP-NS, C-NS and C-S).
doi:10.1371/journal.pone.0010886.g004
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events, and it co-localized with HO-1 in macrophages from PSP-S
patients. This finding suggests a role of HIF-1a in inducing HO-1
expression in this condition. Since hypoxia/reoxygenation alone
without CS exposure did not induce HIF-1a in macrophages of
PSP-NS patients, our data suggest that CS preconditioning is
required for the hypoxia/reoxygenation induction of HIF-1a
expression. Such a relationship was further supported by in vitro
experiments in macrophages exposed to CS then hypoxia and
reoxygenation, to mimic conditions occurring during the pneu-
mothorax condition and treatment in smokers [12]. In these
experiments, HO-1 induction was suppressed by selective HIF-1a
Figure 5. Confocal laser microscopy analysis of HIF-1a and CD68 expression in lung macrophages. A: Immunofluorescent staining was
performed with HIF-1a (in red: left column) and CD68 (in green) and TO-PRO-3 DNA (blue). Co-expression is seen by double staining and overlays
(Merge column) (magnification 61200). B: Quantification of nuclear HIF-1a immunofluorescence in macrophages of C-NS, C-S, PSP-NS and PSP-S
patients. Abbreviations are in Figure 1. Box-and-whiskers plot with median, interquartile range and minimum and maximum values. *p=0.003 PSP-S
vs. PSP-NS, C-NS and C-S. Images are representative of all samples.
doi:10.1371/journal.pone.0010886.g005
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HIF-1a in inducing HO-1 expression in different cell types
[27,28]. However, recently, Li et al. suggested that hypoxia and
ethyl-3,4-dihydroxybenzoate (a prolyl-hydroxylase inhibitor) treat-
ments differentially regulate HO-1 expression through HIF-1a-
independent pathways and that HIF-1a is unlikely to function as a
key regulator for HO-1 in human cell lines [29]. These findings fit
well with our data. Indeed, with no CS exposure, as in PSP-NS
Figure 6. Confocal laser microscopy analysis of HIF-1a and HO-1 expression in lung macrophages. A: Immunofluorescent staining was
performed with HIF-1a (in red: left column) and HO-1 (in green) and TO-PRO-3 DNA (blue). Co-expression is seen by double staining and overlays
(Merge column). B: Quantification of nuclear HIF-1a immunofluorescence and cellular HO-1 immunofluorescence in macrophages of C-NS, C-S, PSP-
NS and PSP-S patients (magnification 61200). Abbreviations are in Figure 1. Box-and-whiskers plot with median, interquartile range and minimum
and maximum values. *p,0.0001 for HO-1 and p=0.001 for HIF-1a: PSP-S vs. PSP-NS, C-NS and C-S. Images are representative of all samples.
doi:10.1371/journal.pone.0010886.g006
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of HIF-1a and, subsequently HO-1 was not induced. However,
the moderate duration and/or intensity of the hypoxia period
could explain this finding. For example, Knowles et al. [30]
reported HIF-1a protein accumulation in PMA-differentiated
THP-1 cells after 16 h of 0.1% O2 hypoxia, values that are greater
than our conditions (4 h at 5% and 0.5% O2). Similar protocols
were used in alveolar epithelial cells to show induced HIF-1a
expression by hypoxia [31]. Interestingly, HIF-1a gene silencing
abrogated the induced expression of not only HO-1 but also BVR
and H-ferritin. We believe this is the first demonstration of a role
of HIF-1a in inducing BVR and H-ferritin gene expression. These
data are in line with recent results showing that hypoxia induces
BVR expression in the human proximal tubule cell line HK-2
[32]. Moreover, in previous studies, HIF-1a was shown to
transcriptionally regulate the expression of proteins such as
transferrin involved in iron homeostasis [33].
Because HIF-1a was upregulated only in PSP-S patients and in
hypoxia/reoxygenation cells, but only when they were pre- and
concomitantly exposed to CS, we investigated the mechanism(s)
underlying this facilitator effect of CS. We focused on Nrf2
because this transcription factor is a central player in inducing the
expression of antioxidant genes in response to a xenobiotic
aggression, such as CS exposure [34,35]. However, Nrf2 protein
expression was not induced in C-S or PSP-S patients or in cells
exposed to CS and hypoxia/reoxygenation. Nrf2 seems not to play
a major role in HO-1 induction in PSP-S patients.
This study has some limitations. First, the number of patients in
each group was low, especially in the PSP-NS group. This limited
number of patients is justified by our intention to include patients
with a similar time course between symptoms and thoracostomy
and between thoracostomy and surgical pleurodesis, to facilitate
the comparison between groups. Second, the association of data
from patient lung tissue and in vitro data may be questioned. A
major aim of the study was to provide a mechanistic explanation
for the results observed in patients. Therefore, we chose the cell
type in which the expression of HO-1 and related proteins was
induced (macrophages) and designed an experimental set-up to
mimic as close as possible conditions occurring during the
pneumothorax condition and treatment in smokers. Although this
strategy has limitations, the concordance of most of the results
concerning HO-1 and related protein expression and HIF-1a
expression between data from patients and in vitro data supports
the validity of this approach. Moreover, THP-1 cells exposed to
CS allowed us to mimic and provide mechanisms potentially
involved in decreased HO-1 expression in alveolar macrophages
in smoking-induced pulmonary emphysema [9,10]. Our results do
not explore the link between redox changes and PSP pathophys-
iology (i.e., our results do not explain how subpleural blebs occur
and promote PSP development). Because our results were
observed in PSP-S and not PSP-NS patients argues against a
phenomenon of pure re-expansion acute lung injury but deserves
further investigation. A mouse model of provoked pneumothorax
would be helpful but does not mimick spontaneous pneumothorax.
Therefore, candidate transcription factors involved in the link
between oxidative stress and hypoxia/reoxygenation in macro-
phages in this model may be non relevant in human.
In conclusion, although the primary mechanisms responsible for
spontaneous pneumothorax remain to be elucidated, the present
study suggests that the pathophysiology of the disease could differ
between smokers and nonsmokers and provides a new link
between oxidative stress and hypoxia/reoxygenation in macro-
phages. Furthermore, this study may contribute to a better
knowledge of the pathophysiology of other conditions associated
with cigarette smoke exposure in the lung and hypoxia/
reoxygenation, such as consequences of ischemia reperfusion with
lung surgery or vascular diseases.
Materials and Methods
Patients
This study was approved by the local ethics committee, and stored
biopsies were reported to our institutional board (Delegation a la
Recherche Clinique, Assistance Publique - Hopitaux de Paris, Carre
Historique - Hopital Saint-Louis, 1 avenue Claude Vellefaux, 75475
Paris Cedex 10, France/Comite de Protection des Personnes, Ile de
France 1, 1 Place du Parvis Notre-Dame, 75181 Paris cedex 04,
France, reference0811760).Writtenconsentswerenotcollectedsince
our biological collection was constituted before 2004 and confirmed
as surgical waste with the approval of our institutional review board.
However, all patients, informed orally, agreed that part of their
biopsies couldbe used for research, and that the data of our biological
collection were analyzed anonymously with the approval of our
institutional review board. All patients included in this study gave
their verbal consent, which was orally recorded by medical staff, prior
to surgery.
Patients with primary spontaneous pneumo-
thorax. Fifteen patients undergoing surgical pleurodesis and
diagnostic lung biopsies for recurrent primary spontaneous
pneumothorax (PSP) were included. Nine patients were smokers
(PSP-S group) and 6 were nonsmokers (PSP-NS group). Tissue
samples were taken from the resected parenchyma adjacent to
pleura. PSP-S and PSP-NS patients showed similar number and
size of previous occurrence of pneumothoraces, as well as time
between symptoms and chest tube thoracostomy (4–8 h) and
between thoracostomy and biopsies (24–48 h).
Control patients. Normal tissue was obtained from 19
control patients (C). Nine patients were smokers (control smoker
group, C-S) and 10 were nonsmokers (control nonsmoker group,
C-NS). C-S patients were undergoing surgery for resection of a
localised primary lung carcinoma (n=8) or a benign lesion (n=1).
C-NS patients were undergoing surgery for resection of a localised
primary lung carcinoma (n=6), lung metastases (n=1) or a benign
lesion (n=3). Tissue samples were taken at a site distant from the
pathological process, in macroscopically and microscopically
normal regions adjacent to pleura.
Figure 7. HIF-1a mRNA expression in lung tissue. Box-and-
whiskers plot with median, interquartile range and minimum and
maximum values. Abbreviations are in Figure 1. Results are expressed as
ratio of expression to that of Ubiquitin-c. * PSP-S vs. C-NS: p=0.03, vs.
CS: p=0.02, vs. PSP-NS: p=0.04.
doi:10.1371/journal.pone.0010886.g007
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PLoS ONE | www.plosone.org 9 May 2010 | Volume 5 | Issue 5 | e10886Figure 8. HO-1, BVR, H-ferritin, 4-HNE expression and ROS production in THP-1 cells. Specific immunocytochemical staining of HO-1 (A),
BVR (B), H-ferritin (C) and 4-HNE (D) (magnification 6200) was performed in THP-1 cells exposed for 4 h to normoxic (21% O2) or hypoxic (5% and
0.5% O2) conditions and 1 mg/ml CS or DMSO (Control) 18 h after re-oxygenation (R18). No staining was observed when the specific antibodies were
replaced by a control isotype antibody or a normal rabbit serum (data not shown). Images are representative of all samples. ROS production (E) was
assessed by H2DCFH-DA oxidation 2 h (R2), 6 h (R6) and 18 h after re-oxygenation (R18) in 4 experiments in duplicate. Box-and-whiskers plot with
median, interquartile range and minimum and maximum values. (n=4, * p=0.029 vs. Ctrl and # p=0.029 vs. 21% O2).
doi:10.1371/journal.pone.0010886.g008
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PLoS ONE | www.plosone.org 10 May 2010 | Volume 5 | Issue 5 | e10886Clinical characteristics of patients are in Table S1. As expected,
patients with PSP were younger than C patients, and their
cumulative tobacco exposure was lower than that of C-S patients.
Processing of lung samples
Lung tissue fragments (about 0.2 cm
3) were immediately frozen
in liquid nitrogen and stored at 280uC for RNA, protein and
immunostaining analysis. The histopathologic features of biopsies
were evaluated on paraffin-embedded sections to exclude features
of emphysema, necrotizing infections, neoplasms, Langerhans’ cell
histocytosis, lymphangioleiomyomatosis and pulmonary fibrosis.
Quantitative RT-PCR analysis
Total RNA was extracted from frozen lung tissue and THP-1
cells (Nucleospin RNAII, Macherey Nagel, Du ¨ren, Germany) and
reverse transcribed. HO-1, BVR, H-ferritin, HIF-1a mRNA
expression was quantified by quantitative real-time PCR
(MX3000P, Stratagene, La Jolla, CA) as described [36] and
expressed as a ratio of expression to that of Ubiquitin-c (Table 3).
Immunohistochemical analysis
Immunohistochemistry was performed as previously described
[9]. Cryostat sections 4-6 mm thick or chamber slides (THP-1 cells)
were fixed in acetone and reacted with appropriate dilutions of
antibodies. Primary antibodies were against human HO-1 (1:1000
dilution, Stressgen, Le-Perray-en-Yvelines, France), BVR (1:1000,
Stressgen), CD68 (macrophage marker; 1:50 Clone PG-M1; Dako,
Glostrup, Denamark), Major Basic Protein (MBP; eosinophil
marker; 1:30, Clone BMK13; Oxford Biotechnology Ltd,
Kidlington, UK), H-ferritin (1:10000 rHO2 kindly provided by
Dr Paolo Santambrogio, San Raffaele Institute, University of
Milano, Italy), elastase (neutrophil marker; 1:100, Clone NP57,
Dako) and 4-HNE (1:5000, Calbiochem, San Diego, CA).
Positive cells were revealed by use of the Vectastain ABC-
alkaline phosphatase kit (Vector Laboratories, Burlingame, CA)
and the fast red substrate (Dako AAPAAP kit system, Glostrup,
Denamark). To test the specificity of the immunostaining,
antibodies were replaced by an isotype-matched control antibody
or normal rabbit serum, with no positive cells identified (data not
shown). On adjacent sections, positive cells with characteristic
macrophage morphology were evaluated in 10 different high-
power fields at 6200 magnification by 2 independent observers,
and results were expressed as the number of positive cells per
millimeter square lung tissue for CD68, MBP and elastase or as
percentage of CD68-positive macrophages positive for HO-1,
BVR, H-ferritin or 4-HNE. The intensity of protein staining in
lung biopsies and THP-1 cells was graded from 0 (absent) to ++
(intense staining). Complete agreement in scoring was obtained
between the 2 independent observers.
Confocal laser scanning microscopy
Double-immunofluorescence labeling was performed to coloca-
lize CD68 or HO-1 with HIF-1a or Nrf2 in lung biopsies and Nrf2
with HIF-1a in THP-1 cells, as previously described [9]. Cryostat
sections 10 mm thick and THP-1 cells in chamber slides were fixed
in 4% paraformaldehyde, saturated with 50 mM NH4Cl and
permeabilised with 0.1% Triton X100. After saturation with
normal serum from the species used to produce the secondary
antibodies, slides were incubated with the appropriate dilution of
primary antibodies (1:10 HIF-1a [Santa Cruz Biotechniology,
Santa Cruz, CA], 1:25 Nrf2 [Santa Cruz Biotechnology], 1:10
CD68; 1:1000 HO-1) before the addition of secondary fluorescent-
labelled antibodies (1:750 dilution) (for HIF-1a, Alexa Fluor 568-
conjugated antimouse; for Nrf2, Alexa Fluor 488-conjugated
antirabbit for THP-1 cells and Alexa Fluor 546-conjugated
antirabbit for lung biopsies; for CD68 and HO-1, Alexa Fluor
488-conjugated antimouse and antirabbit, repectively) and treated
with RNAse A (1 mg/ml). Cell nuclei were localized on DNA
staining with TO-PRO-3 (0.4 mg/ml) (Molecular Probes, Oregon,
USA). Slides were mounted with Prolong Gold anti-fade reagent
(Invitrogen, Carlsbad, CA) and examined by confocal laser
scanning microscopy (LSM-510-META microscope; Zeiss, Ober-
kochen, Germany). To quantify fluorescence intensity per
macrophage, macrophage area was delimited for 100 macrophag-
Table 2. Quantification of HO-1-, BVR-, H-ferritin- and 4-HNE-positive cells after hypoxia and 18 h reoxygenation for the indicated
conditions.
21% O2 5% O2 0.5% O2
Control CS 1 mg/ml Control CS 1 mg/ml Control CS 1 mg/ml
HO-1 staining 0 100 [100–100] 99.7 [98.7–100] 100 [100–100] 1.1 [0–3.6] *, # 100 [100–100] 0 [0–3.8] *, #
+ 0 [0–0] 0.3 [0–1.3] 0 [0–0] 93.2 [88.5–95.5] * # 0 [0–0] 92.9 [90.9–95.4] * #
++ 0 [0–0] 0 [0–0] 0 [0–0] 5.7 [4.5–7.9] * # 0 [0–0] 5.3 [4.6–9.1] * #
BVR staining 0 93.5 [89.9–97.3] 91.4 [86.7–93.6] 91.2 [89.2–93.1] 11.3 [9.9–13.6] * # 84.5 [83.3–96.3] 0 [0–0] * # {
+ 6.5 [2.7–10.1] 8.6 [6.4–13.3] 8.8 [6.9–10.8] 84.1 [82.4–86.8] * # 15.5 [3.7–16.7] 1.8 [0–3] * # {
++ 0 [0–0] 0 [0–0] 0 [0–0] 4.3 [3.3–4.6] * # 0 [0–0] 98.2 [97–100] * # {
H-ferritin staining 0 97.9 [96.6–99.1] 89.4 [86.5–97.3] 97 [95.2–98.7] 3.6 [3.1–7.6] * # 88.7 [86.1–97.4] 0 [0–0] * # {
+ 2.1 [0.9–3.4] 10.6 [2.7–13.5] 3 [1.3–4.8] 91.8 [88.6–95.2] * # 11.3 [2.6–13.9] 10.1 [6.2–16.3] {
++ 0 [0–0] 0 [0–0] 0 [0–0] 3.2 [1–7.3] * # 0 [0–0] 89.9 [83.7–93.8] * # {
4-HNE staining 0 91.7 [87.8–95.9] 85.5 [71.4–93.1] 89.9 [83.8–94.3] 3.1 [1.2–5.4] * # 95.5 [93–98.6] 0 [0–0] * # {
+ 8.3 [4.1–12.2] 14.5 [6.9–28.6] 10.1 [5.7–16.2] 82.4 [78.8–88.9] * # 4.5 [1.4–7] 3.3 [1.4–6.5] # {
++ 0 [0–0] 0 [0–0] 0 [0–0] 14.3 [8.8–17.4] * # 0 [0–0] 96.7 [93.5–98.6] * # {
0 = absent staining; + = moderate staining; ++ = intense staining.
CS = cigarette smoke condensate; HO-1 = heme oygenase-1; BVR = biliverdin reductase; 4-HNE = 4-hydroxynonenal.
Results are presented as median [min-max] percentage, * p=0.029 vs Control, # p=0.026 vs 21% O2, { p=0.029 vs 5% O2.
doi:10.1371/journal.pone.0010886.t002
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PLoS ONE | www.plosone.org 11 May 2010 | Volume 5 | Issue 5 | e10886Figure 9. Expression of HIF-1a and Nrf2 protein in THP-1 cells at 4 h reoxygenation. HIF-1a and Nrf2 protein expression in THP-1 cells
exposed to normoxic (21% O2) or hypoxic (5% and 0.5% O2) conditions and 1 mg/ml CS or DMSO (Ctrl) 4 h after reoxygenation (R4) was assessed by
confocal laser microscopy analysis. A: Immunofluorescent staining involved HIF-1a (in red: left column), Nrf2 (in green) and TO-PRO-3 DNA (blue). Co-
expression is seen by overlays (Merge column). B: Quantification of nuclear HIF-1a and Nrf2 immunofluorescence in THP-1 cells at R4. (magnification
61200). Box-and-whiskers plot with median, interquartile range and minimum and maximum values. * p,0.0001 vs. Ctrl and # p,0.0001 vs. 21% O2.
doi:10.1371/journal.pone.0010886.g009
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PLoS ONE | www.plosone.org 12 May 2010 | Volume 5 | Issue 5 | e10886Figure 10. Expression of HIF-1a and Nrf2 protein in THP-1 cells at 6 h reoxygenation. HIF-1a and Nrf2 protein expression in THP-1 cells
exposed to normoxic (21% O2) or hypoxic (5% and 0.5% O2) conditions and 1 mg/ml CS or DMSO (Ctrl) 6 h after reoxygenation (R6) was assessed by
confocal laser microscopy analysis. A: Immunofluorescent staining involved HIF-1a (in red: left column), Nrf2 (in green) and TO-PRO-3 DNA (blue). Co-
expression is seen by overlays (Merge column). B: Quantification of nuclear HIF-1a and Nrf2 immunofluorescence in THP-1 cells at R4. (magnification
61200). Box-and-whiskers plot with median, interquartile range and minimum and maximum values.
doi:10.1371/journal.pone.0010886.g010
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PLoS ONE | www.plosone.org 13 May 2010 | Volume 5 | Issue 5 | e10886es. For cellular fluorescence intensity, the total number of pixels
corresponding to Alexa Fluor 568 or Alexa Fluor 488 fluorescence
in these areas was determined. For nuclear fluorescence intensity,
the total number pixels corresponding to Alexa Fluor 568 or Alexa
Fluor 488 fluorescence associated with TO-PRO-3 (nucleus
marker) fluorescence was subsequently determined (Start LSM
Image browser). Results were expressed as the intensity of cellular
HO-1 immunofluorescence or nuclear HIF-1a and Nrf2 immu-
nofluorescence per macrophage. No labelling was observed when
primary antibodies were replaced by appropriate isotype-matched
control antibodies or normal serum.
Preparation of lung homogenates for western blot
analysis
Lung biopsy samples were homogenised in 10 mM Tris-HCl,
pH 6.8, 1% SDS, 5% glycerol. Aliquots were stored at 280uC
with 10% Protease Inhibitor Cocktail (Sigma-Aldrich, Saint
Quentin Fallavier, France). Western blot analysis was performed
as described [9] with anti-HO-1 antibody (1:3000). Results are
expressed as a ratio of expression to that of b-actin (1:3000;
monoclonal anti-b-actin antibody, Sigma-Aldrich).
In vitro experiments
Cell culture and cigarette smoke condensate. The THP-
1 cell line was purchased from the American Type Culture
Collection (TIB202, ATCC, Rockville, MD). Cells were grown as
previously described [10] in RPMI1640 in the presence of 10%
fetal calf serum (FCS), 5.10
25 M b-mercapto-ethanol, 4 mM L-
glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin
(complete medium) and differentiated with PMA (30 ng/ml) for
24 h. Cells were washed and re-incubated in complete medium
with 0.1-1-10 mg/ml cigarette smoke condensate (CS) dispersed in
0.1% dimethyl sulfoxide (DMSO) in preliminary experiments, as
previously described [10]. CS concentration was expressed as
micrograms per milliliter for comparison with literature data [37].
CS was prepared by the use of a smoking machine (Anitech,
Paris, France). The particulate matter from Kentucky standard
cigarettes (2R4F; University of Kentucky, KY, USA) was collected
on Cambridge glass fiber filters, and the amount obtained was
determined by weight increase of the filter. The collected smoke
particulates were dissolved in DMSO to yield a 20 mg/ml
solution, and aliquots were stored at 280uC.
The control condition consisted of cells incubated in DMSO at
the same concentration as for cells cultured in the presence of CS.
Exposure to hypoxia and reoxygenation. For both
normoxia and hypoxia exposure, cells were overlayed with a
thin layer of complete medium (0.2 ml/cm
2) to decrease the
diffusion distance of the ambient gas. Cells were placed in a
humidified 12 L airtight Lwoff chamber (Lequeux, Paris, France)
as previously described [38] and flushed with the following gas
mixtures (Air Liquid, Paris, France): 5% CO2/90% N2/5% O2
(moderate hypoxia), 5% CO2/94.5% N2/0.5%O2 (severe
hypoxia) and 5% CO2/74% N2/21% O2 (normoxia control).
The gas was infused continuously into the chamber at 5 L/min for
10 min through a manometer (Air Liquid, HBS 300/1, Paris,
France) placed at the entrance of the chamber as previously
described under oxy-capnometer control (Datex Ohmeda,
Trappes, France) [38]. Cells were exposed to these conditions at
37uC for 4 h and then transferred to the normoxic condition for
2-, 4-, 6- and 18-h reoxygenation. The PO2 levels measured in
culture medium at the steady state were 5.3, 9.3 and 18.7 kPa for
0.5%, 5%, and 21% O2, respectively (ABL800, Radiometer
Figure 11. Effect of HIF-1a silencing on HO-1 protein expression in THP-1 cells. Cells were transfected with 300 nM siRNA for HIF-1a (siHIF) or
nonsilencing siRNA (siCTRL). HO-1 protein expression was assessed by western blot analysis in transfected-THP-1 cells exposed to normoxic (21% O2)o r
hypoxic (5% and 0.5% O2) conditions and 1 mg/ml CS or DMSO (Ctrl) 18 h after reoxygenation (R18). A: Representative western blot of HO-1 protein
expressionin THP-1cells 70 h after transfectionwith 300 nM siRNAforHIF-1a(siHIF)ornonsilencingsiRNA(siCTRL), withb-actincontrol.B:Quantificationof
HO-1 protein. Results are expressed as a ratio to b-actin protein concentration (n=4, *p= 0.005 vs. Ctrl, # p=0.005 vs. 21% O2, { p=0.009 vs. siCTRL).
doi:10.1371/journal.pone.0010886.g011
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did not differ in pH of culture medium.
Cellular toxicity. Cellular toxicity and viability were assessed
by lactate dehydrogenase (LDH) release in the medium
(cytotoxicity detection kit LDH, Roche, Meylan, France) and
trypan blue exclusion test [10].
Intracellular ROS production. Intracellular ROS
production was quantified by measuring 29,79-dichlorodihydro-
Figure 12. Effect of HIF-1a s i l e n c i n go nH O - 1 ,B V Ra n dH - f e r r i t i nm R N Ae x p r e s s i o ni nT H P - 1c e l l s .Cells were transfected with 300 nM siRNA for
HIF-1a(siHIF)or nonsilencing siRNA(siCTRL). HO-1(A), BVR(B)andH-ferritin(C)mRNA expressionwasassessedbyquantitative RT-PCRanalysisintransfected-
THP-1 cells exposed to normoxic (21% O2) or hypoxic (5% and 0.5% O2) conditions and 1 mg/ml CS or DMSO (Ctrl) 4 h after reoxygenation (R4). Results are
expressed as ratio of expression to that of Ubiquitin-c. (n=4, *p= 0.029 vs. Ctrl, # p=0.029 vs. 21% O2, { p=0.029 vs. 5% O2, { p=0.029 vs. siCTRL).
doi:10.1371/journal.pone.0010886.g012
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described [39]. Briefly, H2DCFH-DA (final concentration in
DMSO, 10 mM) was added 1 h before THP-1 cells stimulation in
96-well plates. Fluorescence was measured at 480–555 nm with use
of a multiwell fluorescence plate reader (Fluorostar BMG). Results
were expressed in fluorescent arbitrary units.
Preparation of THP-1 protein extracts for western blot
analysis. Whole cell extracts were obtained by lysing THP-1
cells in lysis buffer (150 mM NaCl, 10 mM HEPES, pH 8,
500 mM saccharose, 1 mM Na2EDTA, 1% Nonidet P40).
Aliquots of cellular extracts were stored at 280uC with 10%
protease inhibitor cocktail. Protein concentration was determined
by the Bradford method (Quickstart, Bio-Rad, Marnes-la-
Coquette, France). Western blot analysis was performed as
described [10]. Primary anti-HO-1 was the same as described
previously (1:3000 dilution). Protein expression was quantified by
densitometric analysis under light with use of a charge-coupled
device camera and an image analyzer (VisioCapt-Bio1D, Fisher
Bioblock Scientific, Illrisch, France). Results are expressed as ratio
of expression to that of b-actin (1:3000 dilution).
siRNA transfection. Cells were transfected with 300 nM
HIF-1a small interfering RNA (siRNA; NM_181054
Dharmacon SMARTpool siRNA reagent; Dharmacon,
Lafayette, CO) or negative control siRNA (Dharmacon plus
nontargeting pool) with Transpass R2 transfecting reagent (New
England BioLabs, Ipswich, MA) as per the manufacturers’
instructions [9].
Briefly, HIF-1a or negative control siRNA was added to the
transfecting reagent diluted in serum-free medium and incubated
for 20 min for the formation of the transfection complex. The
siRNA transfection complexes were added at a final concentration
of 300 nM to 5610
5 cells/well in 6-well plates (for western blot
analysis) or 10
5 cells/well in chamber slides (for confocal analysis)
and incubated for 4 h, then fresh complete medium was added.
Target protein knockdown was assessed 24 to 70 h posttransfec-
tion by confocal analysis with anti- HIF-1a antibody and RT-
PCR. Under these conditions, the transfected cells looked
morphologically normal, and viability did not differ from that
for untransfected cells.
Statistical analysis
Data were analysed by use of Statview software (Abacus
Concepts, Inc.) and displayed for patients as medians and ranges
and for in vitro data as mean and SD. Between-group differences
were first assessed by nonparametric ANOVA (Kruskal-Wallis
test). In the case of global significant difference, between-group
comparisons were assessed by nonparametric Mann-Whitney U-
test. Categorical data were analysed by chi-square test. A p,0.05
was considered statistically significant.
Supporting Information
Figure S1 Expression of HO-1 (A), BVR (B) and H-ferritin (C)
mRNA in lung tissue from C-NS, C-S, PSP-NS and PSP-S patients.
C-NS and C-S, control patient nonsmokers and smokers, respective-
ly; PSP-NS and PSP-S, primary spontaneous pneumothorax
nonsmokers and smokers, respectively. Box-and-whiskers plot with
median, interquartile range and minimum and maximum values.
Results are expressed as ratio of expression to that of Ubiquitin-c.
* for HO-1: PSP-S vs. C-NS: p=0.0004, vs. CS: 0.0003, vs. PSP-NS:
p=0.02; for BVR: PSP-S vs. C-NS: p=0.004, vs. CS: p=0.002, vs.
PSP-NS: p=0.02; for H-ferritin: PSP-S vs. C-NS: p=0.002, vs. CS:
p=0.004, vs. PSP-NS: p=0.003.
Found at: doi:10.1371/journal.pone.0010886.s001 (0.21 MB TIF)
Figure S2 Confocal laser microscopy analysis of Nrf2 expression
in lung biopsies. Quantification of nuclear Nrf2 immunofluores-
cence in macrophages of C-NS, C-S, PSP-NS and PSP-S patients.
Abbreviations are in Figure S1. Box-and-whiskers plot with
median, interquartile range and minimum and maximum values.
(p=0.99).
Found at: doi:10.1371/journal.pone.0010886.s002 (0.09 MB TIF)
Figure S3 mRNA expression of HO-1 (A), BVR (B) and H-ferritin
(C) in THP-1 cells exposed to normoxic (21% O2) or hypoxic (5%
and 0.5% O2) conditions and 1 mg/ml CS or DMSO (Control) 4 h
(R4), 6 h (R6) and 18 h (R18) after reoxygenation. *p= 0.029 vs.
Ctrl, # p=0.029 vs. 21% O2, + p=0.029 vs. 5% O2.
Found at: doi:10.1371/journal.pone.0010886.s003 (0.66 MB TIF)
Figure S4 HIF-1alpha mRNA expression in THP-1 cells
exposed to normoxic (21% O2) or hypoxic (5% and 0.5% O2)
conditions and 1 mg/ml CS or DMSO (Control). Panel A: at 2 h
reoxygenation (R2), panel B: at 6 h reoxygenation (R6), panel C:
at 18 h reoxygenation (R18). Results are expressed as ratio
of expression to that of Ubiquitin-c. *p= 0.029 vs. Ctrl and
# p=0.029 vs. 21% O2.
Found at: doi:10.1371/journal.pone.0010886.s004 (0.30 MB TIF)
Table S1 Clinical characteristics of patients.
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